Document is current
Any future updates will be listed below
-
Authors
Richardson, James K.
Ellmers, Toby J.
-
Funding
Funding for this research was provided by:
Newman Family Foundation
- License Information
-
More Information
Article History
Received: 26 July 2022
Accepted: 17 November 2022
First Online: 26 November 2022
Declarations
:
: Institutional ethical approval was obtained from Brunel University London College of Health and Life Sciences Ethics Committee, protocol number: 17755-MHR-Sep/2019- 20430–3. Protocol title: Adaptive Stepping and Cognitive Factors. The research performed in accordance with principles laid down by the Declaration of Helsinki. All participants provided written informed consent prior to participation.
: Not applicable.
: Dr. Richardson, along with colleagues James T. Eckner, MD, James Ashton-Miller, PhD, and Hogene Kim, PhD, has a patent on the ReacStick device used in the reported research. The device is currently being marketed and sold, solely to researchers, through an LLC, Mineurva.com. Dr. Richardson’s son, Ian Richardson, is the sole owner of the LLC. Dr. Richardson does not have a financial interest in the LLC. Dr. Richardson provided Dr. Ellmers with the device gratis after the latter expressed interest in ReacStick for research purposes. Dr. Richardson was not involved in any aspect of data collection for the research reported here.
